Published in J Virol on June 01, 1998
Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. J Virol (2001) 0.93
Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem J (2004) 0.89
The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules. J Virol (2002) 0.87
Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development. Immunology (1999) 0.85
CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency. J Virol (2004) 0.83
Immunosuppression in early postnatal days induces persistent and allergen-specific immune tolerance to asthma in adult mice. PLoS One (2015) 0.75
Plaque assay techniques for murine leukemia viruses. Virology (1970) 29.21
CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med (1991) 9.94
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
The B7 and CD28 receptor families. Immunol Today (1994) 6.38
The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol (1993) 5.65
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc Natl Acad Sci U S A (1989) 2.63
The two-signal model of lymphocyte activation twenty-one years later. Immunol Today (1992) 2.62
Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol (1989) 2.41
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS (1992) 1.97
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science (1991) 1.80
CD28 costimulation promotes the production of Th2 cytokines. J Immunol (1997) 1.78
Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science (1989) 1.69
CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol (1992) 1.62
Costimulation of T-cell growth. Curr Opin Immunol (1992) 1.53
The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J Virol (1991) 1.41
Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J Immunol (1992) 1.16
Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J Exp Med (1995) 1.13
Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med (1996) 1.12
Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol (1994) 1.12
Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells. J Virol (1994) 1.09
An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol (1994) 1.03
A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur J Immunol (1990) 1.01
Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J Virol (1996) 1.00
Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS. Immunology (1996) 0.93
Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur J Immunol (1996) 0.93
Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin Immunopathol (1995) 0.90
Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs. J Virol (1994) 0.89
The in vivo mechanism of action of CTLA4Ig. J Immunol (1996) 0.89
Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell Immunol (1995) 0.88
Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus. Lab Invest (1993) 0.86
CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. Eur J Immunol (1996) 0.84
Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses. Adv Immunol (1996) 0.84
The murine AIDS virus Gag precursor protein binds to the SH3 domain of c-Abl. J Virol (1997) 0.83
Immunologic havoc induced by the 60 kD Gag protein of the MAIDS defective virus. Leukemia (1997) 0.79
Population dynamics of CD4+ T cells lacking Thy-1 in murine retrovirus-induced immunodeficiency syndrome (MAIDS). Scand J Immunol (1994) 0.79
Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (1993) 3.49
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med (1997) 2.51
HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.80
Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol (1995) 1.78
Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res (1986) 1.75
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol (1999) 1.57
Misdiagnosed malignancy in transplanted organs. Transpl Int (1993) 1.40
Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL/Ka mice. Int J Cancer (1979) 1.35
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Natl Acad Sci U S A (1997) 1.35
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med (1994) 1.17
Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians. Ann Oncol (2006) 1.16
Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology (1995) 1.13
Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization. Eur J Immunol (1984) 1.12
High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology (2005) 1.10
The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry (1998) 1.10
Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol (1995) 1.07
Varicella-zoster virus open reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties. J Virol (1997) 1.07
Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05
Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol (1996) 1.03
Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. J Endocrinol (2003) 1.02
AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res (1994) 1.02
The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol Today (1997) 1.02
Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology (2002) 1.02
Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol (2008) 1.01
A mathematical model of the indirect effects of rotavirus vaccination. Epidemiol Infect (2009) 1.01
Cytochemistry of mouse mast cell reaction to polylysine. Histochemistry (1980) 1.00
Calcifying fibrous tumour of the gastric wall. Histopathology (2004) 1.00
An isolated cardiac conduction disease maps to chromosome 19q. Circ Res (1995) 0.98
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol (2002) 0.97
Do effector and memory T helper cells also need B7 ligand costimulatory signals? J Immunol (1997) 0.96
The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science (1986) 0.96
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clin Belg (2002) 0.95
Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol (1998) 0.94
Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol (1998) 0.94
Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response. J Immunol (1995) 0.93
Proviral genome of radiation leukemia virus: molecular cloning of biologically active proviral DNA and nucleotide sequence of its long terminal repeat. J Virol (1985) 0.93
Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer (1990) 0.93
The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J Surg Res (1994) 0.93
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? Eur J Clin Microbiol Infect Dis (2014) 0.93
Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol (1998) 0.92
Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol (1997) 0.92
Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures. Endocrinology (2000) 0.90
Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. J Pathol (1997) 0.90
Improved four-color flow cytometry method using fluo-3 and triple immunofluorescence for analysis of intracellular calcium ion ([Ca2+]i) fluxes among mouse lymph node B- and T-lymphocyte subsets. Cytometry (1996) 0.89
Organization of transcribed and nontranscribed chromatin in isolated nuclei of Zea mays root cells. Eur J Cell Biol (1981) 0.89
[Clinical case of the month. Intrapulmonary lung sequestration diagnosed in an adult]. Rev Med Liege (2011) 0.89
Genetic imbalances in preleukemic thymuses. Biochem Biophys Res Commun (2001) 0.89
Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein. J Gen Virol (1996) 0.88
Effect of interferon-gamma and tumor necrosis factor-alpha on lymphoepithelial interactions within thymic nurse cells. Eur J Immunol (1990) 0.88
Viral glycoproteins in herpesviridae granulomas. Am J Dermatopathol (1994) 0.88
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma. Br J Cancer (2010) 0.88
Functional analysis of ZNF85 KRAB zinc finger protein, a member of the highly homologous ZNF91 family. DNA Cell Biol (1998) 0.88
The thymus as a neuroendocrine organ. Synthesis of vasopressin and oxytocin in human thymic epithelium. Ann N Y Acad Sci (1987) 0.88
The neurohormonal thymic microenvironment: immunocytochemical evidence that thymic nurse cells are neuroendocrine cells. Neuroendocrinology (1988) 0.87
Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology (1995) 0.87
Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha. Am J Pathol (1995) 0.87
Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells. Oncogene (1998) 0.87
Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol (1996) 0.87
Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol (1998) 0.87
Marrow-thymus interactions during radiation leukemogenesis in C57BL/Ka mice. Cancer Res (1981) 0.86
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model. Transplantation (2000) 0.86
Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. Acta Gastroenterol Belg (2001) 0.85
Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development. Immunology (1999) 0.85
Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch (2000) 0.85
Analysis by in situ hybridization of cells expressing mRNA for tumor-necrosis factor in the developing thymus of mice. Dev Immunol (1992) 0.84
[Cause of death determined at autopsy in the University Hospital of Liège. Developments from 1878 to 1986]. Rev Med Liege (1992) 0.84
Congenital mesoblastic nephroma and trisomy 11. Cancer Genet Cytogenet (1998) 0.84
Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol (1999) 0.84
Detection of infectious centers in C57BL/Ka lymphoid cell populations infected in vitro by the radiation leukemia virus. Cancer Res (1980) 0.83
Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch (1995) 0.83
Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. Mod Pathol (1994) 0.83
The organotypic culture of HPV-transformed keratinocytes: an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions. Vaccine (2001) 0.83
Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells. Immunol Res (1995) 0.83
Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations. Histopathology (1993) 0.83
Further studies on the mechanism of radiation induced thymic lymphoma prevention by bone marrow transplantation in C57BL mice. Leukemia (1989) 0.83
Distribution of varicella-zoster virus gpI and gpII and corresponding genome sequences in the skin. J Med Virol (1995) 0.82
High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Histopathology (2008) 0.82
Plasmacytoma of the thyroid: a case report, a study with use of the immunoperoxidase technique, and a review of the literature. Surgery (1987) 0.82
Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network. J Neuroimmunol (2005) 0.82
In vitro propagated dendritic cells from patients with human-papilloma virus-associated preneoplastic lesions of the uterine cervix: use of Flt3 ligand. Cancer Immunol Immunother (1998) 0.82
[Anatomic-clinical confrontation. Large pelvic mass in a young man]. Rev Med Liege (2002) 0.81
Dendritic cells induce the death of human papillomavirus-transformed keratinocytes. FASEB J (2001) 0.81
Phenotypic characterization of mice of thymus target cells susceptible to productive infection by the radiation leukemia virus. J Natl Cancer Inst (1981) 0.81
p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments. Anticancer Res (1998) 0.81